Profil
Jason Koh is the founder of Marrow Access Technologies, Inc., founded in 2017, where the title held is Chief Medical Officer & Director.
Current jobs include Director at The Harvard Club of Chicago and Portfolio Manager at Linden Advisors LP since 2004.
Former job includes Senior Distressed Analyst at Sandell Asset Management Corp.
Education includes undergraduate degree from The University of Chicago.
Postes actifs de Jason Koh
| Sociétés | Poste | Début |
|---|---|---|
Linden Advisors LP
Linden Advisors LP Investment ManagersFinance Linden principally invests in their convertible strategy and credit strategy. The firm employs a flexible, multi-strategy investment approach which seeks to deliver market neutrality, capital preservation and positive risk-adjusted returns. | Portfolio Manager-Fixed Income | 01/02/2004 |
The Harvard Club of Chicago
The Harvard Club of Chicago Miscellaneous Commercial ServicesCommercial Services Operates membership organizations | Directeur/Membre du Conseil | - |
MFr Technologies, Inc. (Minnesota)
MFr Technologies, Inc. (Minnesota) Medical SpecialtiesHealth Technology Manufactures orthopedic medical devices for marrow stimulation therapy | Fondateur | 01/01/2017 |
Anciens postes connus de Jason Koh
| Sociétés | Poste | Fin |
|---|---|---|
Sandell Asset Management Corp.
Sandell Asset Management Corp. Investment ManagersFinance SAM uses a global, event-driven, multi-strategy investment approach that focuses on merger-arbitrage, equity-event, and distressed credit investments. The firm generally invests fund assets in a portfolio of event-sensitive securities which may include a variety of US and non-US equity and debt securities and other financial and investment interests, instruments and property. The funds' portfolios typically include securities of companies that are subject to mergers, takeover bids, exchange offers, tender offers, spin-offs, liquidations, recapitalizations, corporate restructurings and other similar extraordinary corporate events. SAM is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Corporate Officer/Principal | - |
Formation de Jason Koh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sandell Asset Management Corp.
Sandell Asset Management Corp. Investment ManagersFinance SAM uses a global, event-driven, multi-strategy investment approach that focuses on merger-arbitrage, equity-event, and distressed credit investments. The firm generally invests fund assets in a portfolio of event-sensitive securities which may include a variety of US and non-US equity and debt securities and other financial and investment interests, instruments and property. The funds' portfolios typically include securities of companies that are subject to mergers, takeover bids, exchange offers, tender offers, spin-offs, liquidations, recapitalizations, corporate restructurings and other similar extraordinary corporate events. SAM is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Finance |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Harvard Club of Chicago
The Harvard Club of Chicago Miscellaneous Commercial ServicesCommercial Services Operates membership organizations | Commercial Services |
Linden Advisors LP
Linden Advisors LP Investment ManagersFinance Linden principally invests in their convertible strategy and credit strategy. The firm employs a flexible, multi-strategy investment approach which seeks to deliver market neutrality, capital preservation and positive risk-adjusted returns. | Finance |
MFr Technologies, Inc. (Minnesota)
MFr Technologies, Inc. (Minnesota) Medical SpecialtiesHealth Technology Manufactures orthopedic medical devices for marrow stimulation therapy | Health Technology |
















